{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:54:16Z","timestamp":1793919256575,"version":"4.8.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"L\u2019Association des Scl\u00e9rodermiques de France"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim of this study was to determine the association between various histological patterns and prognosis in patients with SSc and histologically proven muscle involvement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A multicentre retrospective study was conducted of a cohort of scleroderma patients who had undergone muscle biopsy. The biopsies were reviewed in a coordinated manner to classify patients based on the histological findings. Three different patterns were observed: fibrosing myopathy (FMy), inflammatory myopathy (IMy), and immune-mediated necrotizing myopathy (IMNMy). Rates of survival, muscle relapse, and cardiac and pulmonary events were compared between these three groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the 71 scleroderma patients with muscle biopsy specimens available for review, 33 (46.5%) were classified in the FMy group, 18 (25.5%) in the IMy group and 20 (28%) in the NMy group. The median follow-up time was 6.4\u2009years (interquartile range, 2.2\u201310.9\u2009years), and 21 patients died during follow-up, primarily from heart disease and infections. The 10-year survival rate after the first non-RP symptom was 80%, and the cumulative incidence of muscle relapse was 25%. Neither factor differed significantly between the three groups. The risk of pulmonary events was lowest in the IMy group, significantly lower than in the FMy group (hazard ratio, 0.17; 95% CI, 0.04\u20130.67) and non-significantly lower than in the IMNMy group (hazard ratio, 0.28; 95% CI, 0.06\u20131.24). The risk of cardiac events did not differ significantly between the three groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The mortality rate in scleroderma patients with muscle involvement was not associated with their histological patterns.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae407","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T18:28:58Z","timestamp":1723573738000},"page":"1949-1958","source":"Crossref","is-referenced-by-count":3,"title":["Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesions"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8802-1935","authenticated-orcid":false,"given":"No\u00e9mie","family":"Le Gouellec","sequence":"first","affiliation":[{"name":"Department of Nephrology and Internal Medicine, H\u00f4pital de Valenciennes , Valenciennes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louai","family":"Zaidan","sequence":"additional","affiliation":[{"name":"Department of Histopathology, H\u00f4pital Henri Mondor, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Paris Est-Cr\u00e9teil University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5448-7860","authenticated-orcid":false,"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases of Ile de France, East and West, Cochin Hospital, AP-HP, Paris Cit\u00e9 University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Periou","sequence":"additional","affiliation":[{"name":"Department of Histopathology, H\u00f4pital Henri Mondor, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Paris Est-Cr\u00e9teil University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-6471","authenticated-orcid":false,"given":"Emeline","family":"Cailliau","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, CHU de Lille , Lille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Dhote","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Avicenne, AP-HP, Sorbonne Paris Nord University , Bobigny,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Rivi\u00e8re","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Saint Antoine, AP-HP, Sorbonne University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurdagul","family":"Uzunhan","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, H\u00f4pital Avicenne, AP-HP, Sorbonne Paris Nord University, Reference Center for Rare Pulmonary Diseases , Bobigny,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1156-0607","authenticated-orcid":false,"given":"Christian","family":"Agard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases of Ile de France, East and West, University of Nantes , Nantes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Godeau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Henri Mondor, AP-HP, Paris Est-Cr\u00e9teil University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Henri Mondor, AP-HP, Paris Est-Cr\u00e9teil University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Rare Systemic Autoimmune and Autoinflammatory Diseases, CHU Lille, University of Lille , Inserm, Lille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases of Ile de France, East and West, Cochin Hospital, AP-HP, Paris Cit\u00e9 University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-2052","authenticated-orcid":false,"given":"Jerome","family":"Authier","sequence":"additional","affiliation":[{"name":"Department of Histopathology, H\u00f4pital Henri Mondor, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Paris Est-Cr\u00e9teil University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"2025040212095305100_keae407-B1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2025040212095305100_keae407-B2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2025040212095305100_keae407-B3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2013.868512","article-title":"Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"2025040212095305100_keae407-B4","doi-asserted-by":"crossref","first-page":"e21734","DOI":"10.1097\/MD.0000000000021734","article-title":"Myopathy is a risk factor for poor prognosis of patients with systemic sclerosis: a retrospective cohort study","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2025040212095305100_keae407-B5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3899\/jrheum.151425","article-title":"Patients with systemic sclerosis\/polymyositis overlap have a worse survival rate than patients without it","volume":"43","author":"Bhansing","year":"2016","journal-title":"J Rheumatol"},{"key":"2025040212095305100_keae407-B6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-8703(93)90075-K","article-title":"Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association","volume":"125","author":"Follansbee","year":"1993","journal-title":"Am Heart J"},{"key":"2025040212095305100_keae407-B7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/03009741003774626","article-title":"Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features","volume":"39","author":"Ranque","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"2025040212095305100_keae407-B8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10067-004-0975-7","article-title":"Clinical and laboratory features of scleroderma patients developing skeletal myopathy","volume":"24","author":"Mimura","year":"2005","journal-title":"Clin Rheumatol"},{"key":"2025040212095305100_keae407-B9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2008.095919","article-title":"A descriptive and prognostic study of systemic sclerosis-associated myopathies","volume":"68","author":"Ranque","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2025040212095305100_keae407-B10","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/acr.22620","article-title":"Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness","volume":"67","author":"Paik","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2025040212095305100_keae407-B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1759720X16671928","article-title":"Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation","volume":"9","author":"Corallo","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025040212095305100_keae407-B12","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/acr.23291","article-title":"Association of fibrosing myopathy in systemic sclerosis and higher mortality","volume":"69","author":"Paik","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2025040212095305100_keae407-B13","doi-asserted-by":"crossref","first-page":"SI82","DOI":"10.1093\/rheumatology\/keac361","article-title":"Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort","volume":"62","author":"Matas-Garc\u00eda","year":"2023","journal-title":"Rheumatology"},{"key":"2025040212095305100_keae407-B14","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025040212095305100_keae407-B15","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol. juill"},{"issue":"6","key":"2025040212095305100_keae407-B16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"Maurizio Zompatori and Marius Hoeper","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"2025040212095305100_keae407-B17"},{"key":"2025040212095305100_keae407-B18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord NMD"},{"key":"2025040212095305100_keae407-B19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord NMD"},{"key":"2025040212095305100_keae407-B20","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025040212095305100_keae407-B21","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1007\/s00296-011-2301-4","article-title":"Predictors of early mortality in systemic sclerosis: a case-control study comparing early versus late mortality in systemic sclerosis","volume":"32","author":"Derk","year":"2012","journal-title":"Rheumatol Int"},{"key":"2025040212095305100_keae407-B22","doi-asserted-by":"crossref","first-page":"102431","DOI":"10.1016\/j.autrev.2019.102431","article-title":"Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: a comparative study in 52 patients","volume":"19","author":"Chaigne","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2025040212095305100_keae407-B23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212095305100_keae407-B24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00296-015-3382-2","article-title":"Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival","volume":"37","author":"Fern\u00e1ndez-Codina","year":"2017","journal-title":"Rheumatol Int"},{"key":"2025040212095305100_keae407-B25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","article-title":"Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression","volume":"43","author":"Pieroni","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212095305100_keae407-B26","doi-asserted-by":"crossref","first-page":"e18\u201347","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025040212095305100_keae407-B27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-021-02305-3","article-title":"Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology","volume":"141","author":"Siegert","year":"2021","journal-title":"Acta Neuropathol (Berl)"},{"key":"2025040212095305100_keae407-B28","doi-asserted-by":"crossref","first-page":"e12840","DOI":"10.1111\/nan.12840","article-title":"Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis","volume":"48","author":"Ellezam","year":"2022","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae407\/58884050\/keae407.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1949\/58884050\/keae407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1949\/58884050\/keae407.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T16:26:11Z","timestamp":1743611171000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/1949\/7732921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8,13]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae407","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,8,13]]}}}